ABSTRACT Introduction: The 2015 Global Meningococcal Initiative (GMI) meeting discussed
the global importance of meningococcal disease (MD) and its continually changing …

As reviewed in this paper, meningococcal disease epidemiology varies substantially by
geographic area and time. The disease can occur as sporadic cases, outbreaks, and large …

Introduction Invasive meningococcal disease (IMD) is uncommon but still causes
considerable public health burden due to its high mortality and morbidity. This review aims …

The clinical spectrum of invasive meningococcal disease is diverse with meningitis and/or
septicaemia being the commonest modes of presentation. The severity of manifestations of …

The characterization of pathogenic isolates plays a pivotal role in the epidemiology of
infectious diseases, generating the information necessary for identifying, tracking, and …

The epidemiology of invasive meningococcal disease continues to change rapidly, even in
the three years since the first Meningococcal Exchange Meeting in 2008. Control of disease …

We assess risks of communicable diseases that are associated with mass gatherings (MGs),
outline approaches to risk assessment and mitigation, and draw attention to some key …

Meningitis is an inflammation of the protective membranes called meninges and fluid
adjacent the brain and spinal cord. The inflammatory progression expands all through …

Meningococcal disease remains an important cause of morbidity and death worldwide
despite the development and increasing implementation of effective vaccines. Elimination of …

No broadly effective vaccines are available for prevention of group B meningococcal
disease, which accounts for> 50% of all cases. The group B capsule is an autoantigen and …